BRCA1 and BRCA2 are well-known breast cancer genes associated with a significantly increased risk of hereditary breast and ovarian cancer. However, there are an additional eleven genes associated with elevated risk for these types of cancer.
Edwards expects new TAVR approval in mid-2025 to boost sales
Listen to the article 4 min This audio is auto-generated. Please let us know if you have feedback. Edwards Lifesciences predicted Wednesday that an expanded